vs
Amarin Corp plc（AMRN）与REGIS CORP（RGS）财务数据对比。点击上方公司名可切换其他公司
REGIS CORP的季度营收约是Amarin Corp plc的1.3倍（$57.1M vs $45.1M），REGIS CORP净利率更高（0.8% vs -23.3%，领先24.1%），REGIS CORP同比增速更快（22.3% vs 7.0%），过去两年REGIS CORP的营收复合增速更高（7.8% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
AMRN vs RGS — 直观对比
营收规模更大
RGS
是对方的1.3倍
$45.1M
营收增速更快
RGS
高出15.3%
7.0%
净利率更高
RGS
高出24.1%
-23.3%
两年增速更快
RGS
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $57.1M |
| 净利润 | $-10.5M | $456.0K |
| 毛利率 | — | — |
| 营业利润率 | 35.5% | 10.8% |
| 净利率 | -23.3% | 0.8% |
| 营收同比 | 7.0% | 22.3% |
| 净利润同比 | 33.0% | -94.0% |
| 每股收益（稀释后） | — | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNRGS
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $57.1M | ||
| Q3 25 | $49.7M | $59.0M | ||
| Q2 25 | $72.7M | $60.4M | ||
| Q1 25 | $42.0M | $57.0M | ||
| Q4 24 | $62.3M | $46.7M | ||
| Q3 24 | $42.3M | $46.1M | ||
| Q2 24 | $67.5M | $49.4M |
净利润AMRNRGS
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $456.0K | ||
| Q3 25 | $-7.7M | $1.4M | ||
| Q2 25 | $-14.1M | $116.5M | ||
| Q1 25 | $-15.7M | $250.0K | ||
| Q4 24 | $-48.6M | $7.6M | ||
| Q3 24 | $-25.1M | $-853.0K | ||
| Q2 24 | $1.5M | $91.2M |
毛利率AMRNRGS
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
营业利润率AMRNRGS
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 10.8% | ||
| Q3 25 | -22.4% | 10.0% | ||
| Q2 25 | -22.0% | 12.1% | ||
| Q1 25 | -39.9% | 8.8% | ||
| Q4 24 | -84.3% | 11.8% | ||
| Q3 24 | -59.5% | 4.6% | ||
| Q2 24 | -0.8% | — |
净利率AMRNRGS
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | 0.8% | ||
| Q3 25 | -15.6% | 2.3% | ||
| Q2 25 | -19.4% | 192.9% | ||
| Q1 25 | -37.4% | 0.4% | ||
| Q4 24 | -78.0% | 16.4% | ||
| Q3 24 | -59.4% | -1.9% | ||
| Q2 24 | 2.3% | 184.7% |
每股收益（稀释后）AMRNRGS
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $0.16 | ||
| Q3 25 | $-0.02 | $0.49 | ||
| Q2 25 | $-0.03 | $43.67 | ||
| Q1 25 | $-0.04 | $0.08 | ||
| Q4 24 | $-0.12 | $2.71 | ||
| Q3 24 | $-0.06 | $-0.36 | ||
| Q2 24 | $0.00 | $38.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $18.4M |
| 总债务越低越好 | — | $113.3M |
| 股东权益账面价值 | — | $188.7M |
| 总资产 | $645.8M | $588.3M |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资AMRNRGS
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $18.4M | ||
| Q3 25 | $286.6M | $16.6M | ||
| Q2 25 | $298.7M | $17.0M | ||
| Q1 25 | $281.8M | $13.3M | ||
| Q4 24 | $294.2M | $10.2M | ||
| Q3 24 | $305.7M | $6.3M | ||
| Q2 24 | $306.7M | $10.1M |
总债务AMRNRGS
| Q1 26 | — | — | ||
| Q4 25 | — | $113.3M | ||
| Q3 25 | — | $111.3M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | — | $112.0M | ||
| Q4 24 | — | $111.5M | ||
| Q3 24 | — | $95.2M | ||
| Q2 24 | — | $99.5M |
股东权益AMRNRGS
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $188.7M | ||
| Q3 25 | $458.9M | $187.6M | ||
| Q2 25 | $464.9M | $185.6M | ||
| Q1 25 | $473.7M | $68.6M | ||
| Q4 24 | $486.2M | $66.7M | ||
| Q3 24 | $531.4M | $56.4M | ||
| Q2 24 | $551.9M | $56.8M |
总资产AMRNRGS
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $588.3M | ||
| Q3 25 | $659.8M | $592.1M | ||
| Q2 25 | $670.1M | $599.0M | ||
| Q1 25 | $655.7M | $511.2M | ||
| Q4 24 | $685.3M | $530.1M | ||
| Q3 24 | $750.6M | $508.9M | ||
| Q2 24 | $799.9M | $530.5M |
负债/权益比AMRNRGS
| Q1 26 | — | — | ||
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $1.7M |
| 自由现金流经营现金流 - 资本支出 | — | $891.0K |
| 自由现金流率自由现金流/营收 | — | 1.6% |
| 资本支出强度资本支出/营收 | — | 1.4% |
| 现金转化率经营现金流/净利润 | — | 3.65× |
| 过去12个月自由现金流最近4个季度 | — | $14.9M |
8季度趋势，按日历期对齐
经营现金流AMRNRGS
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $1.7M | ||
| Q3 25 | $-12.7M | $2.3M | ||
| Q2 25 | $16.6M | $6.8M | ||
| Q1 25 | $-12.5M | $6.2M | ||
| Q4 24 | $-13.3M | $2.1M | ||
| Q3 24 | $-2.4M | $-1.3M | ||
| Q2 24 | $-2.7M | $5.1M |
自由现金流AMRNRGS
| Q1 26 | — | — | ||
| Q4 25 | — | $891.0K | ||
| Q3 25 | — | $1.9M | ||
| Q2 25 | — | $6.2M | ||
| Q1 25 | — | $5.9M | ||
| Q4 24 | — | $1.7M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $5.1M |
自由现金流率AMRNRGS
| Q1 26 | — | — | ||
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 10.3% | ||
| Q1 25 | — | 10.3% | ||
| Q4 24 | — | 3.6% | ||
| Q3 24 | — | -3.0% | ||
| Q2 24 | — | 10.3% |
资本支出强度AMRNRGS
| Q1 26 | — | — | ||
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% |
现金转化率AMRNRGS
| Q1 26 | — | — | ||
| Q4 25 | — | 3.65× | ||
| Q3 25 | — | 1.68× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | — | 0.28× | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.81× | 0.06× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
